An Asthma Mobile Intervention to Promote Patient-Reported Outcomes in Primary Care

Montefiore Medicine Academic Health System

Status: Completed

Conditions: Asthma

Treatments: Other: ASTHMAXcel mobile application; Other: Outpatient primary care

Study type: Interventional

Funder types: Other

Identifiers

NCT03847142

R18HS025645 (U.S. AHRQ Grant/Contract)

2018-9027

Details and patient eligibility

About

Through this study, the investigators will adapt the ASTHMAXcel mobile app and evaluate the adapted intervention through a randomized controlled trial.

Full description

Through this study, the investigators will use patient and provider feedback to adapt the ASTHMAXcel mobile intervention, and will conduct a randomized controlled trial to test the intervention's impact on clinical and process outcomes.

Enrollment: 110 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

English-speaking individuals >18 years with:

1. persistent asthma(diagnosis made by a healthcare provider) on a daily controller medication
2. able to give informed consent
3. Smartphone (iOS or Android) access

Exclusion criteria

1. use of oral corticosteroids in the 2 weeks prior to the baseline visit
2. pregnancy
3. severe psychiatric or cognitive problems that would prohibit an individual from completing the protocol
4. patients that previously received ASTHMAXcel

Trial design

Primary purpose: Health Services Research

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)

---

110 participants in 2 patient groups

ASTHMAXcel arm

Experimental group

Description:

The ASTHMAXcel arm represents the study intervention, which is a patient-facing mobile application for adult patients with asthma.

Treatment:

Other: ASTHMAXcel mobile application

Usual care arm

Active Comparator group

Description:

This arm represents usual care delivered in the outpatient primary care setting at the study sites.

Treatment:

Other: Outpatient primary care